Legend Biotech Corp. (LEGN)
20.78
+0.90
(+4.53%)
USD |
NASDAQ |
Aug 31, 16:00
20.79
+0.01
(+0.05%)
After-Hours: 20:00
Legend Biotech Cash from Operations (Annual) : -100.46M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -100.46M |
| December 31, 2024 | -141.42M |
| December 31, 2023 | -384.47M |
| December 31, 2022 | -200.01M |
| December 31, 2021 | -197.40M |
| Date | Value |
|---|---|
| December 31, 2020 | -223.21M |
| December 31, 2019 | -83.06M |
| December 31, 2018 | 307.68M |
| December 31, 2017 | -2.376M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Dianthus Therapeutics, Inc. | -129.06M |
| Gilead Sciences, Inc. | 10.02B |
| Ironwood Pharmaceuticals, Inc. | 127.04M |
| Arbutus Biopharma Corp. | -39.64M |
| Fortress Biotech, Inc. | -71.34M |